Send mail to Author

Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer : a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme (Article)

Please indicate your contact information and select, which author you want to contact.



 
 __   _      ___                _____     ______     ___    
| || | ||   / _ \\      ___    |  ___||  /_   _//   / _ \\  
| '--' ||  | / \ ||    /   ||  | ||__    `-| |,-   / //\ \\ 
| .--. ||  | \_/ ||   | [] ||  | ||__      | ||   |  ___  ||
|_|| |_||   \___//     \__ ||  |_____||    |_||   |_||  |_||
`-`  `-`    `---`       -|_||  `-----`     `-`'   `-`   `-` 
                         `-`
 


Back to frontdoor view

OPUS4 Logo